|
Condensed Consolidated Statements of Operations (Unaudited) (USD $)
In Thousands, except Share data, unless otherwise specified |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
|
Jun. 30, 2014
|
Jun. 30, 2013
|
Jun. 30, 2014
|
Jun. 30, 2013
|
|
| Income Statement [Abstract] | ||||
| Revenue | $ 2,459 | $ 2,777 | $ 4,024 | $ 4,265 |
| Operating expenses: | ||||
| Research and development | 6,901 | 5,960 | 13,724 | 11,617 |
| General and administrative | 3,774 | 2,449 | 7,035 | 4,416 |
| Total operating expenses | 10,675 | 8,409 | 20,759 | 16,033 |
| Loss from operations | (8,216) | (5,632) | (16,735) | (11,768) |
| Other income (expense) | ||||
| Interest expense, net | (72) | (51) | (156) | (104) |
| Other income (expense), net | (156) | (236) | 125 | (336) |
| Total other income (expense) | (228) | (287) | (31) | (440) |
| Net loss | (8,444) | (5,919) | (16,766) | (12,208) |
| Accretion of redeemable convertible preferred stock | (1,412) | (2,749) | ||
| Net loss attributable to common stockholders | $ (8,444) | $ (7,331) | $ (16,766) | $ (14,957) |
| Net loss per share attributable to common stockholders: | ||||
| Basic and diluted | $ (0.51) | $ (3.32) | $ (1.02) | $ (6.83) |
| Weighted average common shares outstanding: | ||||
| Basic and diluted | 16,464,410 | 2,210,766 | 16,444,210 | 2,190,479 |